Two classes of anti-platelet drugs reduce anatomical infarct size in monkey hearts. - Wikidata - wikimedia - TriplyDB

Two classes of anti-platelet drugs reduce anatomical infarct size in monkey hearts.

Two classes of anti-platelet drugs reduce anatomical infarct size in monkey hearts.

http://www.wikidata.org/entity/Q37277256

about

Myocardial reperfusion injury: looking beyond primary PCI Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery Reduction of early reperfusion injury with the mitochondria-targeting peptide bendavia Cardioprotective Properties of the Platelet P2Y12 Receptor Inhibitor, Cangrelor: Protective in Diabetics and Reliant Upon the Presence of Blood Triple therapy greatly increases myocardial salvage during ischemia/reperfusion in the in situ rat heart.Pharmacologic therapy that simulates conditioning for cardiac ischemic/reperfusion injury.Combined cardioprotectant and antithrombotic actions of platelet P2Y12 receptor antagonists in acute coronary syndrome: just what the doctor ordered.Surrogate and clinical outcomes following ischemic postconditioning during primary percutaneous coronary intervention of ST--segment elevation myocardial infarction: a meta-analysis of 15 randomized trials.Signalling pathways and mechanisms of protection in pre- and postconditioning: historical perspective and lessons for the future.Ischemic Conditioning Attenuates Platelet-Mediated Thrombosis: A Tale of Reverse Translation.The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge.Platelets, diabetes and myocardial ischemia/reperfusion injury.New and revisited approaches to preserving the reperfused myocardium.Cardioprotection--time to take into account clinical complexity: the case of antiplatelet agents : editorial to "two classes of anti-platelet drugs reduce anatomical infarct size in monkey hearts" by Xi-Ming Yang et al.The impact of irreproducibility and competing protection from P2Y12 antagonists on the discovery of cardioprotective interventions.Cangrelor in Percutaneous Coronary Intervention: Current Status and Perspectives.No post-conditioning in the human heart with thrombolysis in myocardial infarction flow 2-3 on admission.Reduction of no-reflow and reperfusion injury with the synthetic 17β-aminoestrogen compound Prolame is associated with PI3K/Akt/eNOS signaling cascade.An overview of protective strategies against ischemia/reperfusion injury: The role of hyperbaric oxygen preconditioning.Cardioprotective Properties of Human Platelets Are Lost in Uncontrolled Diabetes Mellitus: A Study in Isolated Rat Hearts Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection

P2860

Q26991482-A4378EFB-EB35-48BC-B303-AEDA82B9090A Q28072918-BAFB598B-2E96-4680-9EBA-C3A7ABA69D93 Q33919143-EE0F6454-9B14-4966-A286-F2406C3EC984 Q36259660-59E33932-A5DC-4DB9-BDB2-1D9656D95437 Q37277600-44227669-1384-44F1-9417-36E664EEA221 Q38137849-EB5DFE65-4C06-4991-993C-D695A0B5ABB3 Q38168199-0BE88D80-6C09-44AF-8BD9-0D2CB2C011A6 Q38221826-189E5D14-68DB-4DEB-A7A0-5BA6D1BC678A Q38247701-2ACAD0DE-1465-4D88-8582-90FE399FB92D Q38631884-0FD1A4DF-6ECB-4754-9638-8487FC718834 Q38880162-56A63D30-B4BA-4304-9A86-50ADA0FF2AA5 Q39343342-EED31334-6956-4675-ABDB-4B8995B499D5 Q45064238-762FABC6-4A78-4EAA-81B7-255F047E40DD Q47258313-EA73DE14-B069-4353-8FC5-8D9FFDA3284A Q48649274-9DA82794-724F-4715-A47C-76F813A64743 Q49926557-0BEA6A00-1F9C-41E9-8480-981B89C30786 Q51106338-C5690F5D-9833-44C7-9857-76974AA94709 Q54296892-C8C7AB5F-5E87-42AF-8469-06191AD0FA19 Q54920287-7DFFBA7D-B4E7-4E89-8971-9BDE2A1163BF Q56366840-094BD237-0420-48DE-AC44-7AF3623843AC Q57760906-05AAABCD-1D1E-494D-B6C3-3BC3F4FE5DAA

P2860

Two classes of anti-platelet drugs reduce anatomical infarct size in monkey hearts.

http://www.wikidata.org/entity/Q37277256

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Two classes of anti-platelet drugs reduce anatomical infarct size in monkey hearts.

@en

Two classes of anti-platelet drugs reduce anatomical infarct size in monkey hearts.

@nl

type

label

Two classes of anti-platelet drugs reduce anatomical infarct size in monkey hearts.

@en

Two classes of anti-platelet drugs reduce anatomical infarct size in monkey hearts.

@nl

prefLabel

Two classes of anti-platelet drugs reduce anatomical infarct size in monkey hearts.

@en

Two classes of anti-platelet drugs reduce anatomical infarct size in monkey hearts.

@nl

P1433

Q37277256-95F4E9B5-2917-485A-8CCE-188A71C1FED7

P1476

Q37277256-F407904B-B710-4A43-8AFA-D8ED6B352600

P2093

Q37277256-01AF784E-24C6-4B08-9710-FE8CC4366991

Q37277256-389D8C17-F231-4DC6-8DFD-4143C73CAAB1

Q37277256-4BD65637-687B-4778-BBD6-4EC35DF2B74E

Q37277256-796C9D4F-B991-483F-8FC8-3DBAD0A877F9

Q37277256-BA103BB9-3A16-4894-BC35-B30A601F23D8

Q37277256-BC7B18EE-4E9A-45B6-8656-5B05BF46B409

Q37277256-E313BFA7-A1BA-4886-A708-68BD54A325CD

Q37277256-EF2DDB21-55BF-4F19-BA6B-EC91C24B5000

Q37277256-F42EFE58-1DF7-4FAC-BB08-7BD1B1881F4A

P2860

Q37277256-02D19D28-9A01-4795-9C95-F4C2EA30C57C

Q37277256-16D348DF-D634-4C72-B5F1-0447FDF0723F

Q37277256-2CE85409-50D1-42FC-801E-015964BA2ADA

Q37277256-36A8AEF8-17C1-4936-97DC-89A6D584CF6F

Q37277256-3A1B7AB7-1186-4B90-9726-3BD87F6D82D8

Q37277256-4EC54189-1BC9-4C67-B36C-A31B6B33D257

Q37277256-4F6DBD79-4C53-47F0-968C-7761FBFAE88F

Q37277256-60D32DF5-E8D7-4788-ABDA-F0202704512F

Q37277256-660E4251-F664-42AF-8680-55738281E6AE

Q37277256-6AB7D01F-0D1C-4CDF-9F0A-9F25DA04524B

P304

Q37277256-3E2504D2-E927-48E7-A0E0-598F622B3582

P31

Q37277256-C0C80CD5-F6D5-48DF-B0D0-4F882AD819DF

P356

Q37277256-A6DE8612-78F7-4C4C-B862-1A05020010E9

P433

Q37277256-4CC69E0C-7AFF-4D3E-87E2-BECB2BD40D61

P478

Q37277256-F1173909-6C2F-4DDC-9540-9A25AE5A7A4B

P577

Q37277256-3E640DD5-E940-4651-B118-6FF9F5DBC075

P698

Q37277256-4F7AD19D-C728-4E16-8098-426D85FEF652

P932

Q37277256-E93645C8-628B-4BC1-A17D-30391B58792B

P356

S10557-012-6436-7

P1433

Cardiovascular Drugs and Therapy

P1476

Two classes of anti-platelet drugs reduce anatomical infarct size in monkey hearts.

@en

P2093

James M Downey

http://www.w3.org/2001/XMLSchema#string

Junichi Kambayashi

http://www.w3.org/2001/XMLSchema#string

Lin Cui

http://www.w3.org/2001/XMLSchema#string

Michael V Cohen

http://www.w3.org/2001/XMLSchema#string

Narendra Tandon

http://www.w3.org/2001/XMLSchema#string

Xi-Ming Yang

http://www.w3.org/2001/XMLSchema#string

Xiulan Yang

http://www.w3.org/2001/XMLSchema#string

Yanping Liu

http://www.w3.org/2001/XMLSchema#string

Yongge Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Different effects of tirofiban and aspirin plus clopidogrel on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusion.

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium

Simultaneous integrin alphavbeta3 and glycoprotein IIb/IIIa inhibition causes reduction in infarct size in a model of acute coronary thrombosis and primary angioplasty.

The Fab fragment of a novel anti-GPVI monoclonal antibody, OM4, reduces in vivo thrombosis without bleeding risk in rats.

Platelet P2Y₁₂ blockers confer direct postconditioning-like protection in reperfused rabbit hearts

Myocardial salvage in acute myocardial infarction--challenges in clinical translation

Protecting the acutely ischemic myocardium beyond reperfusion therapies: are we any closer to realizing the dream of infarct size elimination?

P2Y12 platelet inhibition in clinical practice.

Postconditioning during coronary angioplasty in acute myocardial infarction: the POST-AMI trial.

The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow.

P304

109-115

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10557-012-6436-7

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23318690

http://www.w3.org/2001/XMLSchema#string

P932

3816632

http://www.w3.org/2001/XMLSchema#string